Jacobs Levy Equity Management
RXST icon

Jacobs Levy Equity Management’s RxSight RXST Stock Holding History

Jacobs Levy Equity Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.57M Buy
1,066,321
+881,200
+476% +$7.32M 0.03% 371
2025
Q4 		$1.93M Buy
+185,121
New +$1.86M 0.01% 584

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Jacobs Levy Equity Management's RXST Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its RxSight (RXST) stake by 476% in Q1 2026, buying an estimated $7.32M and bringing the position to 1,066,321 shares worth $6.57M. The position accounts for 0.03% of the portfolio, ranked #371.

Jacobs Levy Equity Management first reported a position in RXST in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Jacobs Levy Equity Management held 1,066,321 shares of RxSight worth $6.57M as of Q1 2026.
  • Jacobs Levy Equity Management bought 881,200 RxSight shares in Q1 2026, an estimated $7.32M.
  • RxSight made up 0.03% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #371 holding.
  • Jacobs Levy Equity Management first reported a position in RxSight in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.